A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

Source:http://linkedlifedata.com/resource/pubmed/id/12566306

Cancer Res. 2003 Feb 1 63 3 627-35

Download in:

View as

General Info

PMID
12566306